Global Prostate Biopsy Market 2017-2021

  • ID: 4115441
  • Report
  • Region: Global
  • 97 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Amecath
  • Biomedical
  • Cook Medical
  • Exosome Diagnostics
  • Möller Medical
  • Sterylab
  • MORE
About Prostate Biopsy Market

Biopsy is a clinical procedure primarily used in the detection and extraction of malignant or cancerous cells and their abnormal growth in the body for further analysis and interpretation of diseases. The purpose of removing tissues or cells during the procedure is mainly to limit the spread of tumor, minimize morbidity, and eliminate interference with future treatments.

The analysts forecast the global prostate biopsy market to grow at a CAGR of 12.66% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global prostate biopsy market for 2017-2021. To calculate the market size, the report considers the new sales of devices and products used in prostate biopsy

The market is divided into the following segments based on geography:
- Americas
- EMEA
- APAC

The report, Global Prostate Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- C.R. Bard
- Cook Medical
- Endomed Systems
- SOMATEX Medical Technologies
- Biomedical

Other prominent vendors
- Amecath
- AprioMed
- Argon Medical Devices
- Biopsybell
- Boston Scientific
- Exosome Diagnostics
- MDNA Life Sciences
- MDxHealth
- Möller Medical
- Pathway Genomics
- Predicine
- Sterylab
- TSK Laboratory Europe
- UroMed
- Urotech

Market drivers
- Growing incidences of prostate cancer
- For a full, detailed list, view the full report

Market challenges
- Complications associated with prostate needle biopsies
- For a full, detailed list, view the full report

Market trends
- New product launches and R&D activities
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Amecath
  • Biomedical
  • Cook Medical
  • Exosome Diagnostics
  • Möller Medical
  • Sterylab
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Key market highlights

Prostate cancer: An overview

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by product

Market overview

Global prostate needle biopsy market

Global prostate liquid biopsy market

PART 07: Market segmentation by end-user

Hospitals

ASCs

Diagnostic centers

Key buying criteria

PART 08: Geographical segmentation

Prostate biopsy market in Americas

Prostate biopsy market in EMEA

Prostate biopsy market in APAC

PART 09: Market drivers

Growing incidences of prostate cancer

Recurrent revenue from repeat biopsy tests

Growing number of diagnostic centers

PART 10: Impact of drivers

PART 11: Market challenges

Complications associated with prostate needle biopsies

High cost of biopsy procedure

Inaccurate test results

Limited technical skills

PART 12: Impact of drivers and challenges

PART 13: Market trends

New product launches and R&D activities

Growing demand for MRI and Ultrasound guided prostate biopsy procedures

High growth potential of prostate liquid biopsy tests

Growing focus toward combination of traditional and liquid biopsy tests

PART 14: Vendor landscape

Competitive scenario

PART 15: Key vendor analysis

C.R. Bard

Cook Medical

Endomed Systems

SOMATEX Medical Technologies

Biomedical

Other prominent vendors

PART 16: Appendix

List of abbreviations

PART 17: About the Author

List of Exhibits
Exhibit 01: Incidence rate of prostate cancer in different age groups 2015
Exhibit 02: Stages of prostate cancer and various diagnostics tools used for detection
Exhibit 03: Snapshot of global prostate biopsy market
Exhibit 04: Global prostate biopsy market 2016-2021 ($ millions)
Exhibit 05: Prostate cancer: Key statistics
Exhibit 06: Global prostate biopsy market analysis: Developed and emerging markets
Exhibit 07: Five forces analysis
Exhibit 08: Segmentation of global prostate biopsy market by product type
Exhibit 09: Two most common biopsies for prostate cancer
Exhibit 10: Share of each product type in the global prostate biopsy market 2016 and 2021 (%)
Exhibit 11: Global prostate biopsy market by product analysis 2016
Exhibit 12: Global prostate biopsy market: Lifecycle analysis 2016
Exhibit 13: Segmentation of global prostate biopsy market by product 2016-2021 ($ millions)
Exhibit 14: Segmentation of global prostate biopsy market by product 2016-2021 (%)
Exhibit 15: Global prostate needle biopsy market 2016-2021 ($ millions)
Exhibit 16: Types of prostate biopsy devices
Exhibit 17: Types of prostate biopsy guns
Exhibit 18: Percentage share of reusable and disposable prostate biopsy guns 2016
Exhibit 19: Benefits of advanced biopsy needles
Exhibit 20: Global prostate needle biopsy market segmentation percentage split 2016
Exhibit 21: Global prostate liquid biopsy market 2016-2021 ($ millions)
Exhibit 22: Global prostate biopsy market by end-user 2016 (%)
Exhibit 23: Factors affecting the purchase decision of prostate biopsy devices
Exhibit 24: Global prostate biopsy market segmentation by geography 2016-2021 (%)
Exhibit 25: Global prostate biopsy market analysis by geography 2016
Exhibit 26: Global prostate biopsy market: Geography market growth lifecycle analysis 2016
Exhibit 27: Country wise presence of global prostate biopsy market
Exhibit 28: Geographical overview of global prostate biopsy market 2016-2021
Exhibit 29: Prostate biopsy market in Americas 2016-2021 ($ millions)
Exhibit 30: Prostate biopsy market in EMEA 2016-2021 ($ millions)
Exhibit 31: Prostate biopsy market in APAC 2016-2021 ($ millions)
Exhibit 32: Global prostate biopsy market by geography 2016-2021 ($ millions)
Exhibit 33: Global prostate biopsy market by geography 2016-2021 (%)
Exhibit 34: Impact of drivers
Exhibit 35: Cost of biopsies for uninsured people in US, 2015
Exhibit 36: Impact of drivers and challenges
Exhibit 37: Competitive structure analysis of global prostate biopsy market 2016
Exhibit 38: Competitive parameters in global prostate biopsy market
Exhibit 39: C.R. Bard strength assessment
Exhibit 40: C.R. Bard strategy assessment
Exhibit 41: C.R. Bard opportunity assessment
Exhibit 42: Key highlights of Cook Medical
Exhibit 43: Cook Medical strength assessment
Exhibit 44: Cook Medical strategy assessment
Exhibit 45: Cook Medical opportunity assessment
Exhibit 46: Endomed Systems strength assessment
Exhibit 47: Endomed Systems strategy assessment
Exhibit 48: Endomed Systems opportunity assessment
Exhibit 49: Key highlights of SOMATEX Medical Technologies
Exhibit 50: SOMATEX Medical Technologies strength assessment
Exhibit 51: SOMATEX Medical Technologies strategy assessment
Exhibit 52: SOMATEX Medical Technologies opportunity assessment
Exhibit 53: Key highlights of Biomedical
Exhibit 54: Biomedical strength assessment
Exhibit 55: Biomedical strategy assessment
Exhibit 56: Biomedical opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Amecath
  • Biomedical
  • Cook Medical
  • Exosome Diagnostics
  • Möller Medical
  • Sterylab
  • MORE
New Report Released: – Global Prostate Biopsy Market 2017-2021
The author of the report recognizes the following companies as the key players in the Global Prostate Biopsy Market: C.R. Bard, Cook Medical, Endomed Systems, SOMATEX Medical Technologies, and Biomedical.

Other Prominent Vendors in the market are: Amecath, AprioMed, Argon Medical Devices, Biopsybell, Boston Scientific, Exosome Diagnostics, MDNA Life Sciences, MDxHealth, Möller Medical, Pathway Genomics, Predicine, Sterylab, TSK Laboratory Europe, UroMed, and Urotech.

Commenting on the report, an analyst from the research team said: “One trend in the market is the new product launches and R&D activities. The vendors are concentrating on developing technologically advanced prostate cancer testing tools especially non-invasive methods. Most of the liquid biopsy companies are focusing on spending huge amount in R&D activities and developing new products to enhance the diagnosis of prostate cancer. The molecular diagnostic companies are focusing on developing advanced diagnostic tests based on mitochondrial genome with fast DNS-sequencing machines to lead simple blood tests to cancer. Also, diagnostic companies are collaborating with pharma company for developing non-invasive diagnostic tests.”

According to the report, one driver in the market is the growing incidences of prostate cancer. The rising incidence of prostate cancer is fueling the growth of prostate biopsy market worldwide. Prostate cancer is the second most common cancer prevalent in males after skin cancer. Prostate cancer is found to affect men above 50 years of age and is rare in young men. According to multiple research studies data estimates, approximately, 1.07 million to 1.17 million new prostate cancer cases were recorded in 2012, worldwide. Another disorder associated with prostate gland is benign prostatic hyperplasia BPH (the enlargement of the prostate). This is driving the physicians to adopt prostate biopsies for diagnosis and screening of tumor in the prostate. For instance, according to CDC statistics in 2013, approximately 176,450 million individuals in the US were diagnosed with prostate cancer, while 27,681million men died from the disease.

Further, the report states that one challenge in the market is the Complications associated with prostate needle biopsies
In several reported cases, prostate needles biopsies have been known to cause significant complications among patients. In addition, faulty execution of biopsies can cause damage to nearby tissues or organs, as well as skin numbness around the biopsy site. In about 33% of men who undergo biopsy have side effects and cause a moderate to major problem depending on the patient condition. Side effects such as bleeding, infection, pain, fever, and transient urinary problems. In few cases, individual, would also require hospitalization due to these complications. In addition, in repeat biopsy, the previous exposure to antibiotics can put the individual at potential risk of infections. After prostate needle biopsy, a range of complications can occur that include bacteremia accompanied by sepsis, asymptomatic bacteriuria, and urinary tract infection.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • CR Bard
  • Cook Medical
  • Endomed Systems
  • SOMATEX Medical Technologies
  • Biomedical
  • Amecath
  • AprioMed
  • Argon Medical Devices
  • Biopsybell
  • Boston Scientific
  • Exosome Diagnostics
  • MDNA Life Sciences
  • MDxHealth
  • Möller Medical
  • Pathway Genomics
  • Predicine
  • Sterylab
  • TSK Laboratory Europe
  • UroMed
  • Urotech
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll